Abstract
Increasing in count of middle-aged and elderly people is setting a new direction for the development of medicine. The popular anti-age therapy is aimed at preventing the development and effective treatment of age-associated diseases. For female body the aging process is primarily associated with sex steroids production decreasing. Deterioration of cognitive activity affecting patients' ability to work and social involvement in perimenopausal period. A large number of estrogen and progesterone receptors have been found in different parts of the CNS. These receptors respond to signaling cascades triggered by hormones better during the period of primary estrogen deficiency, which determines the critical window period. Acting from this position, we studied 120 perimenopausal patients, who were divided into four groups: The first, the second and the third groups received different types of MHT, the fourth (control) group didn’t receive any treatment. All participants underwent clinical, laboratory and instrumental examination at the beginning and after 360 days of research. Our results demonstrated the efficacy of early start hormonal therapy to improve the cognitive abilities of women during the menopausal transition.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
